NCT05812378 is a clinical trial in Pulmonary Function Test, sponsored by RTM Vital Signs, LLC.

Who is sponsoring NCT05812378?

NCT05812378 is sponsored by RTM Vital Signs, LLC.

What condition does NCT05812378 study?

NCT05812378 studies Pulmonary Function Test, Tidal Volume, Respiratory Rate, Ventilators, Breathing Sounds.

Is NCT05812378 still recruiting?

NCT05812378 is currently status unknown. Last updated 13 April 2023.

Last reviewed 2023-04-13 · How we verify

NCT05812378

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Respiratory Monitoring System Safety and Performance Study

Status unknown Last updated 13 April 2023

What this trial tests

trial in Pulmonary Function Test in 50 participants. Status unknown.

Timeline

24 March 2023

Primary endpoint
9 December 2023

9 December 2023

Quick facts

Lead sponsor	RTM Vital Signs, LLC
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	50
Start date	24 March 2023
Primary completion	9 December 2023
Estimated completion	9 December 2023
Sites	1 location across United States

Conditions studied

Pulmonary Function Test — all drugs for Pulmonary Function Test →
Tidal Volume — all drugs for Tidal Volume →
Respiratory Rate — all drugs for Respiratory Rate →
Ventilators — all drugs for Ventilators →

Sponsor

RTM Vital Signs, LLC

Who can join

Adults 18 to 80, any sex, with Pulmonary Function Test or Tidal Volume. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is collect data to evaluate the efficacy of the RMS system in monitoring, recording, and presenting respiratory function data to the user in participants scheduled for pulmonary function testing (PFT). Participants will complete: * 60 episodes of data collection with a decreased tidal volume * 30 episodes of data collection with an increased tidal volume * 80 episodes with normal tidal volume breathing The TSS will continuously transmit sound data to an adjacent personal computer (PC) via Bluetooth Low-Energy (BLE). TSS trachea sound data will be recorded on the PC and then transmitted via a secure wireless network to an RTM cloud account that is HIPPA compliant. Reference breathing data will be simultaneously recorded using an FDA approved hospital ventilator (Hamilton Medical, HAMILTON-C1) with a calibrated pneumotach, capnometer, and a tight-fitting face mask. This system accurately measures and records a spontaneously breathing patient's RR, TV, MV, and end-tidal carbon dioxide concentration.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pulmonary Function Test

Currently open trials in the same condition.

NCT06415890 — Effect of 4-7-8 Breathıng Technıque on Shoulder Paın and Respıratory Functıon Tests After Laparoscopıc Cholesectectomy · NA · recruiting

Other RTM Vital Signs, LLC trials

Trials by the same sponsor.

NCT03845699 — Development of an Algorithm That Predicts Hypoventilation Due to an Opioid Overdose · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05812378 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by RTM Vital Signs, LLC
Last refreshed: 13 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05812378.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing